Type I Interferon Therapy Limits CNS Autoimmunity by Inhibiting CXCR3-Mediated Trafficking of Pathogenic Effector T Cells

Weiwei Wang, Jun Chen(Sun Yat-sen University), Igal Gery(Yale University), Sihan Wu(Sun Yat-sen University), Wai Po Chong(National Institutes of Health), Chunmei Li(Sun Yat-sen University), Yizhi Liu(Sun Yat-sen University), Wanjun Chen(National Institutes of Health), Zilin Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Rachel R Caspi(National Institutes of Health), Hongyan Zhou(Sun Yat-sen University), Ying Wan(Shanghai Jiao Tong University)
Cell Reports
July 1, 2019
Cited by 31


Related Papers